Oxysophocarpine (OSC) has been documented for anti-inflammatory activity. However, the mechanisms of OSC in anti-inflammation are unclear. Aim: To investigate the protective effects of OSC on inflammation and apoptosis induced by lipopolysaccharide in NCI-H292 and human primary airway epithelial cells. Materials & methods: MTT and Annexin V-FITC/PI staining were used to detect cells viability. Inflammatory responses were determined by ELISA. The quantitative real-time PCR (qRT-PCR) and western blot were used to detect mRNA/miRNA and protein expressions respectively. Co-immunoprecipitation was investigated for protein interactions. Results & conclusion: miR-155 mimics significantly induced cell apoptosis, inflammatory responses and MAPK and NF-κB pathways. NDFIP1 was identified as the target of miR-155. OSC protected cells against apoptosis and inflammatory responses and compromised miR-155 activity by attenuating MAPK and NF-κB pathways.

Graphical abstract

Keywords:

References

1. Lu Y, Lou J, Liu X, Wang S. Oxysophocarpine reduces oxygen-glucose deprivation-induced microglial activation and injury. Am. J. Transl. Res. 9(5), 2266–2275 (2017).
Medline CASGoogle Scholar
2. Zhu QL, Li YX, Zhou R et al. Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion. Pharm. Biol. 52(8), 1052–1059 (2014).
Medline CASGoogle Scholar
3. Zhao P, Chang RY, Liu N et al. Neuroprotective effect of oxysophocarpine by modulation of MAPK pathway in rat hippocampal neurons subject to oxygen-glucose deprivation and reperfusion. Cell Mol. Neurobiol. 38(2), 529–540 (2018).
Medline CASGoogle Scholar
4. Yang Y, Li YX, Wang HL et al. Oxysophocarpine ameliorates carrageenan-induced inflammatory pain via inhibiting expressions of prostaglandin E2 and cytokines in mice. Planta Med. 81(10), 791–797 (2015).
Medline CASGoogle Scholar
5. Gao J, Li Y, Wang Q, Ma X, Zhang Y. Oxysophocarpine inhibits lung injury induced by respiratory syncytial virus. Am. J. Transl. Res. 9(9), 4083–4093 (2017).
Medline CASGoogle Scholar
6. Rebane A, Akdis CA, MicroRNAs. Essential players in the regulation of inflammation. J. Allergy Clin. Immunol. 132(1), 15–26 (2013).
Medline CASGoogle Scholar
7. Lu TX, Rothenberg ME. Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J. Allergy Clin. Immunol. 132(1), 3–13; quiz 14 (2013).
Medline CASGoogle Scholar
8. Zech A, Ayata CK, Pankratz F et al. MicroRNA-155 modulates P2R signaling and Th2 priming of dendritic cells during allergic airway inflammation in mice. Allergy 70(9), 1121–1129 (2015).
Medline CASGoogle Scholar
9. Subedi A, Park PH. Autocrine and paracrine modulation of microRNA-155 expression by globular adiponectin in RAW 264.7 macrophages: involvement of MAPK/NF-kappaB pathway. Cytokine 64(3), 638–641 (2013).
Medline CASGoogle Scholar
10. Yip KH, Kolesnikoff N, Hauschild N et al. The Nedd4-2/Ndfip1 axis is a negative regulator of IgE-mediated mast cell activation. Nat. Commun. 7, 13198 (2016).
Medline CASGoogle Scholar
11. Hiemstra PS, McCray PB Jr, Bals R. The innate immune function of airway epithelial cells in inflammatory lung disease. Eur. Respir. J. 4, 1150–1162 (2015).
Google Scholar
12. Okoye IS, Czieso S, Ktistaki E et al. Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in mediating allergy and antihelminth immunity. Proc. Natl Acad. Sci. USA 111(30), E3081–E3090 (2014).
Medline CASGoogle Scholar
13. Ma Y, Ge A, Zhu W et al. Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling. Oxid. Med. Cell Longev. 2016, 5843672 (2016).
MedlineGoogle Scholar
14. Inam A, Shahzad M, Shabbir A, Shahid H, Shahid K, Javeed A. Carica papaya ameliorates allergic asthma via down regulation of IL-4, IL-5, eotaxin, TNF-alpha, NF-kB, and iNOS levels. Phytomedicine 32, 1–7 (2017).
Medline CASGoogle Scholar
15. Wang X, Chen Y, Yuan W et al. MicroRNA-155-5p is a key regulator of allergic inflammation, modulating the epithelial barrier by targeting PKIalpha. Cell Death Dis. 10(12), 884 (2019).
Medline CASGoogle Scholar
16. Elaidy SM, Essawy SS, Hussain MA, El-Kherbetawy MK, Hamed ER. Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats. Naunyn Schmiedebergs Arch. Pharmacol. 391(3), 309–321 (2018).
Medline CASGoogle Scholar
17. Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin. Sci. (Lond.) 131(13), 1541–1558 (2017).
Medline CASGoogle Scholar
18. Tarassishin L, Loudi O, Bauman A, Shafit-Zagardo B, Suh HS, Lee SC. Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*. Glia 59(12), 1911–1922 (2011).
MedlineGoogle Scholar
19. Alivernini S, Gremese E, McSharry C et al. MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis. Front. Immunol. 8, 1932 (2017).
MedlineGoogle Scholar
20. Chauhan PS, Singh DK, Dash D, Singh R. Intranasal curcumin regulates chronic asthma in mice by modulating NF-kB activation and MAPK signaling. Phytomedicine 51, 29–38 (2018).
Medline CASGoogle Scholar
21. Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch. Toxicol. 89(6), 867–882 (2015).
Medline CASGoogle Scholar
22. Shang J, Liu W, Yin C, Chu H, Zhang M. Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-kappaB signaling. Mol. Immunol. 114, 571–577 (2019).
Medline CASGoogle Scholar
23. Gilfillan AM, Rivera J. The tyrosine kinase network regulating mast cell activation. Immunol. Rev. 228(1), 149–169 (2009).
Medline CASGoogle Scholar
24. Kathania M, Zeng M, Yadav VN, Moghaddam SJ, Yang B, Venuprasad K. Ndfip1 regulates itch ligase activity and airway inflammation via UbcH7. J. Immunol. 194(5), 2160–2167 (2015).
Medline CASGoogle Scholar
25. Liu R, Peng J, Wang H et al. Oxysophocarpine retards the growth and metastasis of oral squamous cell carcinoma by targeting the Nrf2/HO-1 axis. Cell Physiol. Biochem. 49(5), 1717–1733 (2018).
Medline CASGoogle Scholar

Vol. 12, No. 16

Metrics

Downloaded 82 times

History

Received 20 April 2020

Accepted 27 May 2020

Published online 30 June 2020

Published in print August 2020

Information

Keywords

Acknowledgments

The authors greatly appreciate the technical support from Beijing University of Chinese Medicine and Ganan Medical University.

Financial & competing interests disclosure

This research was funded by the National Natural Science Foundation of China (no. 81860388). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

PDF download